11.02.2018 Views

Creatvie Biolabs Released CreMap™ Epitope Mapping and Discovery Services

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Creatvie</strong> <strong>Biolabs</strong> <strong>Released</strong> CreMap <strong>Epitope</strong> <strong>Mapping</strong> <strong>and</strong> <strong>Discovery</strong> <strong>Services</strong><br />

Creative <strong>Biolabs</strong> is a biotech company specialized in early drug discovery <strong>and</strong><br />

development.<br />

With the common efforts of its scientists, Creative <strong>Biolabs</strong> successfully developed<br />

CreMap <strong>Epitope</strong> <strong>Mapping</strong> <strong>and</strong> <strong>Discovery</strong> <strong>Services</strong> based on its expert knowledge<br />

<strong>and</strong> rich research experience in this field.<br />

With the rapid development of immunology <strong>and</strong> bioinformatics, the techniques used<br />

in T cell <strong>and</strong> B cell epitope prediction <strong>and</strong> discovery have been greatly improved.<br />

However, problems of complicated experimental process, high economic cost, <strong>and</strong><br />

low resolution still remain unsolved. To help solve these problems, Creative <strong>Biolabs</strong>'<br />

academic group has developed the CreMap T cell (or B cell) epitope discovery<br />

platform based on the expert knowledge <strong>and</strong> rich research experience in this field.<br />

“We try our best to provide professional technical services to reduce the project cost,<br />

<strong>and</strong> at the same time improve the experimental accuracy,” Said Dr. Monika, scientific<br />

officer of Creative <strong>Biolabs</strong>.<br />

CreMap T cell epitope discovery platform is an advanced technology for the<br />

analysis of potential T cell epitopes. Compared with other strategies that require a<br />

significant investment of time <strong>and</strong> money, this platform provides an efficient <strong>and</strong> at<br />

the same time cost-effective solution which could be used for the mapping of both<br />

CD4 + <strong>and</strong> CD8 + T cell epitopes in the field of protein drug development or peptide<br />

vaccine design.<br />

In addition, Creative <strong>Biolabs</strong> has also developed an advanced B cell epitope mapping<br />

platform, in which both conformational <strong>and</strong> linear epitopes could be effectively<br />

mapped in high-throughput <strong>and</strong> low cost.<br />

About Creative <strong>Biolabs</strong><br />

Creative <strong>Biolabs</strong> is specialized in providing custom biotechnology <strong>and</strong><br />

pharmaceutical services that cover the full scope of biotechnology needs of early<br />

antibody discovery <strong>and</strong> development. As a trusted provider of the most cost-effective<br />

outsourcing solutions, Creative <strong>Biolabs</strong> has been working for a large number of<br />

satisfied clients from biotechnology <strong>and</strong> pharmaceutical companies as well as<br />

government <strong>and</strong> academic research laboratories all over the world.<br />

http://www.abnewswire.com/adminpreview.php?id=r7moGxk

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!